SKIP TO CONTENT
  • Home
  • About
    • Careers
  • People
  • Practice Areas
    • Patents
    • Trademarks & Brand Protection
    • Copyright
    • IP Strategy
    • IP Transactions
    • Corporate & Business Transactions
    • M&A Advisory
    • VC Due Diligence
  • Industries
  • Newsroom
  • Contact
Make A Payment
Visit us on Visit us on Visit us on
  • Industries
  • Aerospace
  • Artificial Intelligence
  • Biotechnology & Pharmaceuticals
  • Biomedical Devices
  • Financial Services
  • Electronics & Semiconductors
  • Energy & Sustainability
  • Engineering & Robotics
  • Industrial Chemistry
  • Materials Science
Johnson, Marcou, Isaacs & Nix, LLC logo Johnson, Marcou, Isaacs & Nix, LLC logo
Visit us on Visit us on Visit us on
Make A Payment

newsroom

Sep 24 2024

Patent Eligibility of Diagnostic Gene Signature Method Claims

By: Christopher Southgate
By: Christopher Southgate
September 24, 2024
Insights
A claim drafting strategy assuring the patent subject matter eligibility of diagnostic gene signature method claims is discussed in light...
Insights
Read More
Sep 10 2024

Leveraging Patent Term Adjustment Strategies to Add Value to Your Company’s Patent Portfolio

By: John Sears
By: John Sears
September 10, 2024
Patents
A single day of additional patent protection can mean millions of dollars in revenue. This is where effective strategies to maximize Patent...
Patents
Read More
Aug 29 2024

Protecting Your innovation When the Lights Go Out on Noncompetes

By: John Sears
By: John Sears
August 29, 2024
Insights
With the legal landscape in flux after a federal court's blockage of the FTC's noncompete ban, startups should reconsider strategies for...
Insights
Read More
Aug 22 2024

John Sears Named to the 2024 Class of the IAM Strategy 300

By: JMIN
By: JMIN
August 22, 2024
Firm News
JMIN is delighted to announce that IAM, a leader in intellectual property value creation, has selected Senior Partner John Sears […]...
Firm News
Read More
Aug 20 2024

Federal Circuit Clarifies Scope of Obviousness-Type Double Patenting After Curveball Thrown by In re Cellect

By: Brent Nix
By: Brent Nix
August 20, 2024
Insights
In its 2023 decision in In re Cellect, the U.S. Court of Appeals for the Federal Circuit appeared to expand the […]...
Insights
Read More
Page 2 of 6Prev12345...NextLast

Categories

  • Firm News
  • General
  • Insights
  • News
  • Patents
  • Procedure

Articles by Attorneys

Articles by Practices

Archives

Related Posts

  • UniCure Reports Positive 3-Year Huntington’s Gene Therapy Data: Unique IP Considerations for Complex Gene Therapy Programs
  • Willful Enough: How Halozyme Is Putting Merck on Notice
  • Protecting Your innovation When the Lights Go Out on Noncompetes
  • Federal Circuit Clarifies Scope of Obviousness-Type Double Patenting After Curveball Thrown by In re Cellect

subscribe

Subscribe to our newsletter

Contact Us

P: 912-257-4864

E: info@jmin.com

Johnson, Marcou, Isaacs & Nix, LLC

27 City Square, Suite 1
P.O. Box 691

Hoschton, GA 30548

Visit our social media at: https://www.facebook.com/JMINiplaw/ Visit our social media at: https://twitter.com/jmin_iplaw Visit our social media at: https://www.linkedin.com/company/johnson-marcou-isaacs-nix-llc/
MAKE A PAYMENT
© 2025 Johnson, Marcou, Isaacs & Nix, LLC. All Rights Reserved. Sitemap Disclaimer Privacy Policy A PaperStreet Web Design
connect